Terms: = Leukemia AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS
506 results:
1. Clinicopathological characteristics and genomic profiling in patients with transformed lymphoma: a monocentric retrospective study.
Zhao X; Bian H; Hao F; Shao S; Wu C; Zhang Q; Wu M; Li Z; Gao C
Ann Med; 2024 Dec; 56(1):2419556. PubMed ID: 39460552
[TBL] [Abstract] [Full Text] [Related]
2. PBA2, a novel inhibitor of the β-catenin/cbp pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation.
Yang K; Fu K; Zhang H; Wang X; To KKW; Yang C; Wang F; Chen ZS; Fu L
Mol Cancer; 2024 Sep; 23(1):209. PubMed ID: 39342174
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Determinants of Outcome in Acute Lymphoblastic leukemia.
Chang TC; Chen W; Qu C; Cheng Z; Hedges D; Elsayed A; Pounds SB; Shago M; Rabin KR; Raetz EA; Devidas M; Cheng C; Angiolillo A; Baviskar P; Borowitz M; Burke MJ; Carroll A; Carroll WL; Chen IM; Harvey R; Heerema N; Iacobucci I; Wang JR; Jeha S; Larsen E; Mattano L; Maloney K; Pui CH; Ramirez NC; Salzer W; Willman C; Winick N; Wood B; Hunger SP; Wu G; Mullighan CG; Loh ML
J Clin Oncol; 2024 Oct; 42(29):3491-3503. PubMed ID: 39121442
[TBL] [Abstract] [Full Text] [Related]
4. GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma.
He MY; Tong KI; Liu T; Whittaker Hawkins R; Shelton V; Zeng Y; Bakhtiari M; Xiao Y; Zheng G; Sakhdari A; Yang L; Xu W; Brooks DG; Laister RC; He HH; Kridel R
Leukemia; 2024 Oct; 38(10):2210-2224. PubMed ID: 39117798
[TBL] [Abstract] [Full Text] [Related]
5. Identification of genetic subtypes in follicular lymphoma.
Shelton V; Detroja R; Liu T; Isaev K; Silva A; Passerini V; Bakhtiari M; Calvente L; Hong M; He MY; Modi S; Hershenfeld SA; Ludvigsen M; Madsen C; Hamilton-Dutoit S; d'Amore FA; Brodtkorb M; Johnson NA; Baetz T; LeBrun D; Tobin JWD; Gandhi MK; Mungall AJ; Xu W; Ben-Neriah S; Steidl C; Delabie J; Tremblay-LeMay R; Jegede O; Weigert O; Kahl B; Evens AM; Kridel R
Blood Cancer J; 2024 Aug; 14(1):128. PubMed ID: 39112453
[TBL] [Abstract] [Full Text] [Related]
6. Silencing GNAS enhances HDAC3i efficacy in crebbp wild type B cell lymphoma.
Mondello P
Leukemia; 2024 Oct; 38(10):2087-2089. PubMed ID: 39030358
[TBL] [Abstract] [Full Text] [Related]
7. MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML.
Clarke ML; Gabrielsen OS; Frampton J
Adv Exp Med Biol; 2024; 1459():341-358. PubMed ID: 39017851
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating the accuracy of Raman spectroscopy in differentiating leukemia patients from healthy individuals: A systematic review and meta-analysis.
Li S; Gao S; Su L; Zhang M
Photodiagnosis Photodyn Ther; 2024 Aug; 48():104260. PubMed ID: 38950876
[TBL] [Abstract] [Full Text] [Related]
9. A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes.
Smolko AE; Sullivan DW; Olsen SN; Kang H; Whedon SD; Baell JB; Cole PA; Armstrong SA; Kuroda MI
Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2405905121. PubMed ID: 38889153
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of a Promising cbp/p300 Degrader XYD129 for the Treatment of Acute Myeloid leukemia.
Wu T; Hu J; Zhao X; Zhang C; Dong R; Hu Q; Xu H; Shen H; Zhang X; Zhang Y; Lin B; Wu X; Xiang Q; Xu Y
J Med Chem; 2024 Jun; 67(11):9194-9213. PubMed ID: 38829718
[TBL] [Abstract] [Full Text] [Related]
11. The DNA damage-independent ATM signalling maintains cbp/DOT1L axis in MLL rearranged acute myeloid leukaemia.
Wang G; Zhang W; Ren J; Zeng Y; Dang X; Tian X; Yu W; Li Z; Ma Y; Yang P; Lu J; Zheng J; Lu B; Xu J; Liang A
Oncogene; 2024 Jun; 43(25):1900-1916. PubMed ID: 38671157
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of Highly Potent and Efficient cbp/p300 Degraders with Strong
Hu J; Xu H; Wu T; Zhang C; Shen H; Dong R; Hu Q; Xiang Q; Chai S; Luo G; Chen X; Huang Y; Zhao X; Peng C; Wu X; Lin B; Zhang Y; Xu Y
J Med Chem; 2024 May; 67(9):6952-6986. PubMed ID: 38649304
[TBL] [Abstract] [Full Text] [Related]
13. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
[TBL] [Abstract] [Full Text] [Related]
14. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL.
Balducci E; Simonin M; Duployez N; Steimlé T; Dourthe ME; Villarese P; Ducassou S; Arnoux I; Cayuela JM; Balsat M; Courtois L; Andrieu G; Touzart A; Huguet F; Petit A; Ifrah N; Dombret H; Baruchel A; Macintyre E; Preudhomme C; Boissel N; Asnafi V
Blood; 2024 Aug; 144(9):988-1000. PubMed ID: 38518104
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand.
Liu Y; Joy ST; Henley MJ; Croskey A; Yates JA; Merajver SD; Mapp AK
Biochemistry; 2024 Jan; 63(1):1-8. PubMed ID: 38086054
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic targeting of EP300/cbp by bromodomain inhibition in hematologic malignancies.
Nicosia L; Spencer GJ; Brooks N; Amaral FMR; Basma NJ; Chadwick JA; Revell B; Wingelhofer B; Maiques-Diaz A; Sinclair O; Camera F; Ciceri F; Wiseman DH; Pegg N; West W; Knurowski T; Frese K; Clegg K; Campbell VL; Cavet J; Copland M; Searle E; Somervaille TCP
Cancer Cell; 2023 Dec; 41(12):2136-2153.e13. PubMed ID: 37995682
[TBL] [Abstract] [Full Text] [Related]
17. Discovery of a potent and selective cbp bromodomain inhibitor (Y08262) for treating acute myeloid leukemia.
Xiang Q; Wu T; Zhang C; Wang C; Xu H; Hu Q; Hu J; Luo G; Zhuang X; Wu X; Zhang Y; Xu Y
Bioorg Chem; 2024 Jan; 142():106950. PubMed ID: 37924753
[TBL] [Abstract] [Full Text] [Related]
18. DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia.
Campolungo D; Salomé M; Biferali B; Tascini AS; Gabellini D
Sci Adv; 2023 Sep; 9(37):eadi3771. PubMed ID: 37713484
[TBL] [Abstract] [Full Text] [Related]
19. A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I.
Chimge NO; Chen MH; Nguyen C; Zhao Y; Wu X; Gonzalez PG; Ogana H; Hurwitz S; Teo JL; Chen X; Du J; Jin V; Kim YM; Ono M; Argüello RJ; Kahn M
Curr Mol Pharmacol; 2024; 17(1):e060923220758. PubMed ID: 37691195
[TBL] [Abstract] [Full Text] [Related]
20. [A comparative study of the effects of citrate and heparin anticoagulation on coagulation function and efficacy in children with septic shock undergoing continuous blood purification].
Zhong X; Luo S; Ren R; Lai J; Deng G; Zhu H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):856-859. PubMed ID: 37593866
[TBL] [Abstract] [Full Text] [Related]
[Next]